For example, Yervoy (Ipilimumab) manufactured by Bristol-Myers Squibb is the world’s first approved and marketed CTLA-4 antibody drug, which has been used for the treatment of a variety of cancers (Rohaan et al., 2022). This evidence concerns the gene CTLA4 and cancer.